Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1430-2020Class II

Remisol Advance running on hardware with Windows XP, Windows 7, Windows Server 2003 and Windows Server 2008...

Normand-Info S.A.S.U. / initiated 2019-08-15 / Terminated

Normand-Info S.A.S.U. began a recall of Remisol Advance running on hardware with Windows XP, Windows 7, Windows Server 2003 and Windows Server 2008 operating systems on . FDA classified it as Class II and gives the reason as "A patch was released for a critical remote code execution vulnerability in remote desktop services. This vulnerability can be exploited remotely without authentication on certain operating systems. An attacker who...". As of , the recall status on record is Terminated.

Recall record

Recall number
Z-1430-2020
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Normand-Info S.A.S.U.
Product
Remisol Advance running on hardware with Windows XP, Windows 7, Windows Server 2003 and Windows Server 2008 operating systems
Product code
JQP Calculator/Data Processing Module, For Clinical Use
Reason for recall
A patch was released for a critical remote code execution vulnerability in remote desktop services. This vulnerability can be exploited remotely without authentication on certain operating systems. An attacker who successfully exploited this vulnerability could execute arbitrary code on the target system; then install programs; view, change, or delete data; or create new accounts with full user rights. If the vulnerability could be exploited locally, it would lock down the computer.
FDA root cause
Other
Action
On 08/15/19, Urgent Medical Device Recall notices, dated 08/09/19, were mailed to customers informing them to follow the instructions in the notice to download the patch for their system(s). In addition, customers were asked to share this information with laboratory staff, to retain the notification as part of their laboratory Quality System documentation, and to complete and return the response form. If you are a centralized license holder, please provide the other affected laboratories of your organization or association with a copy of this letter. The latest information on cybersecurity can be found on the following website: https://www.beckmancoulter.com/en/about-beckman-coulter/product-security/product-security-updates. Customers with additional questions were encouraged to contact the firm via email at website: http://www.beckmancoulter.com. The following number was also provided: (800) 526-3821
Quantity in commerce
6479
Distribution
U.S.: NY, AZ, FL, NJ, MA, OH, CA, IL, NC, OK, IN, KY, OR, MI, WI, PA, UT, GA, VA, TX, NE, SD, IA, MN, MD, DE, SC, MT, WV, LA, MO, TN, NM, NV, HI, WA, WY, AL, AR, MS, RI, ID, ME, DC, ND, AK, CO, CT, KS, NH, VT
Product codes and lots
All serial numbers

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1430-2020
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1430-2020Class IITerminatedVoluntary: Firm initiated